Heart failure is a highly morbid and mortal clinical condition that represents the last stage of most cardiovascular disorders. Diabetes is strongly associated with an increased incidence of heart failure and directly promotes cardiac hypertrophy, fibrosis, and apoptosis. These changes, in turn, contribute to the development of ventricular dysfunction. The clinical condition associated with the spectrum of cardiac abnormalities induced by diabetes is termed diabetic cardiomyopathy. Myocardial inflammation has recently emerged as a pathophysiological process contributing to cardiac hypertrophy, fibrosis, and dysfunction in cardiac diseases. Myocardial inflammation is also implicated in the development of diabetic cardiomyopathy. Several molecular mechanisms link diabetes to myocardial inflammation. The NF-κB signalling pathway and the renin-angiotensin-aldosterone system are strongly activated in the diabetic heart, thereby promoting myocardial inflammation. Advanced glycation end-products and damage-associated molecular pattern molecules also represent strong triggers for inflammation. The mediators resulting from this inflammatory process modulate specific intracellular signalling mechanisms in cardiac cells that promote the development of diabetic cardiomyopathy. This review article will provide an overview of the signalling molecular mechanisms linking diabetic cardiomyopathy to myocardial inflammation.

An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy / Frati, Giacomo; Schirone, Leonardo; Chimenti, Isotta; Yee, Derek; BIONDI ZOCCAI, Giuseppe; Volpe, Massimo; Sciarretta, Sebastiano. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 113:4(2017), pp. 378-388. [10.1093/cvr/cvx011]

An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy

FRATI, GIACOMO;SCHIRONE, LEONARDO;CHIMENTI, ISOTTA;BIONDI ZOCCAI, GIUSEPPE;VOLPE, Massimo;SCIARRETTA, SEBASTIANO
2017

Abstract

Heart failure is a highly morbid and mortal clinical condition that represents the last stage of most cardiovascular disorders. Diabetes is strongly associated with an increased incidence of heart failure and directly promotes cardiac hypertrophy, fibrosis, and apoptosis. These changes, in turn, contribute to the development of ventricular dysfunction. The clinical condition associated with the spectrum of cardiac abnormalities induced by diabetes is termed diabetic cardiomyopathy. Myocardial inflammation has recently emerged as a pathophysiological process contributing to cardiac hypertrophy, fibrosis, and dysfunction in cardiac diseases. Myocardial inflammation is also implicated in the development of diabetic cardiomyopathy. Several molecular mechanisms link diabetes to myocardial inflammation. The NF-κB signalling pathway and the renin-angiotensin-aldosterone system are strongly activated in the diabetic heart, thereby promoting myocardial inflammation. Advanced glycation end-products and damage-associated molecular pattern molecules also represent strong triggers for inflammation. The mediators resulting from this inflammatory process modulate specific intracellular signalling mechanisms in cardiac cells that promote the development of diabetic cardiomyopathy. This review article will provide an overview of the signalling molecular mechanisms linking diabetic cardiomyopathy to myocardial inflammation.
2017
cardiomyopathy; cytokine; diabetes; heart failure; inflammation
01 Pubblicazione su rivista::01a Articolo in rivista
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy / Frati, Giacomo; Schirone, Leonardo; Chimenti, Isotta; Yee, Derek; BIONDI ZOCCAI, Giuseppe; Volpe, Massimo; Sciarretta, Sebastiano. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 113:4(2017), pp. 378-388. [10.1093/cvr/cvx011]
File allegati a questo prodotto
File Dimensione Formato  
Frati_overview_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 508.95 kB
Formato Adobe PDF
508.95 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/960986
Citazioni
  • ???jsp.display-item.citation.pmc??? 83
  • Scopus 181
  • ???jsp.display-item.citation.isi??? 163
social impact